Trial Details
TERMINATEDBasic Information
| Clinical ID | c3289 |
|---|---|
| Identifier | NCT02272868 |
| Trial Title | Fecal Microbial Transplant in Pediatric Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Fecal Microbial transplant|DRUG: Normal Saline|DRUG: rifaximin+omeprazole+miralax |
Participant Information
| Sponsor | Seattle Children's Hospital |
|---|---|
| City | Seattle |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2015-01 |
|---|---|
| Primary Completion Date | 2016-10-01 |
| Completion Date | 2016-10-01 |